Crossmark

Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers

Crossref DOI link: https://doi.org/10.1007/s10549-020-05607-4

Published Online: 2020-03-31

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Purrington, Kristen S.

Gorski, David

Simon, Michael S.

Hastert, Theresa A.

Kim, Seongho

Rosati, Rayna

Schwartz, Ann G.

Ratnam, Manohar
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (HHSN261201300011I)

National Institutes of Health (P30CA022453)
License Information

Text and Data Mining valid from 2020-03-31

Version of Record valid from 2020-03-31
More Information

Article History

Received: 20 January 2020

Accepted: 21 March 2020

First Online: 31 March 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This article does not contain any studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below